SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 
News in brief

FMC posts earnings, says UK omega-3s facility nearing full scale production

By Hank Schultz , 10-Feb-2014
Last updated on 10-Feb-2014 at 17:28 GMT2014-02-10T17:28:48Z

FMC said its Seal Sands omega-3s production facility will start shipping products in the first quarter of 2014.

FMC said its Seal Sands omega-3s production facility will start shipping products in the first quarter of 2014.

FMC Corporation announced a 24% rise in revenues in its fourth quarter of 2013, hitting $1.1 billion. For the full year of 2013, the company hit $3.9 billion in revenues, a 14% rise over the previous year. In its earnings release, FMC gave an update on the progress of its Seal Sands omega-3 production facility.

The nutrition segment contributed $189.8 million to fourth quarter revenue, repenting a 13% rise year-over-year. Segment earnings of $40.4 million were also 13 percent higher than the prior-year quarter despite operational disruptions related to two natural disasters near the company's Cebu facility in the Philippines.  Business growth was primarily driven by higher volumes of colloidal microcrystalline cellulose and pharmaceutical binders.  Earnings growth was lower than previous guidance due to a delayed startup of the Seals Sands omega-3 production facility which is located in a chemical industry park in northeastern England.  The plant, which was part of FMC’s $345 million purchase of fish oils refiner EPAX last year, is back on track with final testing and regulatory approvals expected to be completed in February 2014 with initial sales expected in the first quarter. 
In addition to nutritional products, FMC, based in Philadelphia, is active in agricultural products and services, which generate the lion’s share of the company’s revenues, and minerals.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars